Disruption of TNF-α/TNFR1 function in resident skin cells impairs host immune response against cutaneous vaccinia virus infection.

TitleDisruption of TNF-α/TNFR1 function in resident skin cells impairs host immune response against cutaneous vaccinia virus infection.
Publication TypeJournal Article
Year of Publication2012
AuthorsTian T, Dubin K, Jin Q, Qureshi A, King SL, Liu L, Jiang X, Murphy GF, Kupper TS, Fuhlbrigge RC
JournalJ Invest Dermatol
Volume132
Issue5
Pagination1425-34
Date Published2012 May
ISSN1523-1747
KeywordsAnimals, Antibodies, Viral, CD8-Positive T-Lymphocytes, Immunity, Innate, Immunoglobulin G, Interferon-gamma, Lymphocyte Count, Mice, Mice, Inbred C57BL, Mice, Knockout, Receptors, Tumor Necrosis Factor, Type I, Skin, Tumor Necrosis Factor-alpha, Vaccinia, Vaccinia virus, Viral Load
Abstract

One strategy adopted by vaccinia virus (VV) to evade the host immune system is to encode homologs of TNF receptors (TNFRs) that block TNF-α function. The response to VV skin infection under conditions of TNF-α deficiency, however, has not been reported. We found that TNFR1-/- mice developed larger primary lesions, numerous satellite lesions, and higher skin virus levels after VV scarification. Following their recovery, VV-scarified TNFR1-/- mice were fully protected against challenge with a lethal intranasal dose of VV, suggesting these mice had developed an effective memory immune response. A functional systemic immune response was further demonstrated by enhanced production of VV-specific IFN-γ and VV-specific CD8(+) T cells in spleens and draining lymph nodes. Interestingly, bone marrow (BM)-reconstitution studies using wild-type (WT) BM in TNFR1-/- host mice, but not TNFR1-/- BM in WT host mice, reproduced the original results seen in TNFR1-/- mice, indicating that TNFR1 deficiency in resident skin cells, rather than hematopoietic cells, accounts for the impaired cutaneous immune response. Our data suggest that lack of TNFR1 leads to a skin-specific immune deficiency, and that resident skin cells have a crucial role in mediating an optimal immune defense to VV cutaneous infection via TNF-α/TNFR1 signaling.

DOI10.1038/jid.2011.489
Alternate JournalJ. Invest. Dermatol.
PubMed ID22318381
PubMed Central IDPMC3326195
Grant ListR01 AI097128 / AI / NIAID NIH HHS / United States
P30 AR042689-06 / AR / NIAMS NIH HHS / United States
R01 AR065807 / AR / NIAMS NIH HHS / United States
P30 AR042689 / AR / NIAMS NIH HHS / United States
HHSN266200400030C / / PHS HHS / United States
P30 AR42689 / AR / NIAMS NIH HHS / United States
HHSN266200400030C / AI / NIAID NIH HHS / United States

Person Type: